Crossmark

Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models

Crossref DOI link: https://doi.org/10.1007/s00330-020-07335-1

Published Online: 2020-10-02

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Choi, Yangsean

Nam, Yoonho

Jang, Jinhee

Shin, Na-Young

Lee, Youn Soo

Ahn, Kook-Jin https://orcid.org/0000-0001-6081-7360
Kim, Bum-soo

Park, Jae-Sung

Jeon, Sin-soo

Hong, Yong Gil
Funding

Funding for this research was provided by:

Ministry of Education (NRF‐2017R1D1A1B03030772)

Catholic University of Korea
License Information

Text and Data Mining valid from 2020-10-02

Version of Record valid from 2020-10-02
More Information

Article History

Received: 27 May 2020

Revised: 10 August 2020

Accepted: 21 September 2020

First Online: 2 October 2020

Compliance with ethical standards

:

: The scientific guarantor of this publication is Kook-Jin Ahn.

: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

: Institutional Review Board approval was obtained.

: Written informed consent was not required for this study because this study is a retrospective cohort study.

: • Cross-sectional study

Document is current

Any future updates will be listed below